太龙药业,600222,收入构成,报告日期,2020-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
分部间抵销,-2729,-2729,0,0%,0%
其他,13,2,11,84.02%,0.05%
药品药材流通,3599,3250,350,9.72%,1.48%
药品研发服务,8193,4289,3904,47.65%,16.51%
药品制造,55699,36318,19381,34.8%,81.96%

太龙药业,600222,收入构成,报告日期,2019-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
药品药材流通,9140,8415,725,7.93%,1.5%
其他（补充）,62,95,-32,-51.91%,-0.07%
药品制造,99547,62692,36855,37.02%,76.09%
药品研发服务,22432,11544,10888,48.54%,22.48%

太龙药业,600222,收入构成,报告日期,2019-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
药品制造,48253,31493,16759,34.73%,78.52%
药品药材流通,4527,4233,294,6.5%,1.38%
其他,44,40,4,8.07%,0.02%
分部间抵销,-3163,-3194,31,-1%,0.15%
药品研发服务,9652,5396,4256,44.09%,19.94%

太龙药业,600222,收入构成,报告日期,2018-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,332,234,98,29.6%,0.24%
医药制造,80827,51920,28907,35.76%,71.88%
药品研发服务,18840,9565,9275,49.23%,23.06%
药品药材流通,19480,17546,1935,9.93%,4.81%

太龙药业,600222,收入构成,报告日期,2018-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,52,53,-1,-1.19%,-0%
分部间抵销,-2632,-2632,0,0%,0%
药品研发服务,7209,3406,3803,52.76%,20.78%
制药制造,39869,26928,12941,32.46%,70.69%
药品流通,13816,12254,1562,11.31%,8.53%

太龙药业,600222,收入构成,报告日期,2017-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,221,107,114,51.5%,0.32%
药品流通,31148,26164,4984,16%,14.02%
药品制造,73080,50844,22236,30.43%,62.55%
药品研发服务,12390,4177,8212,66.28%,23.1%

太龙药业,600222,收入构成,报告日期,2017-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,160,70,90,56.3%,0.62%
分部间抵销,-3514,-3499,-15,0.43%,-0.1%
医药制造,35000,25912,9089,25.97%,62%
医药流通,13213,10763,2450,18.54%,16.71%
技术研发,4482,1437,3046,67.95%,20.78%

太龙药业,600222,收入构成,报告日期,2016-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,322,302,21,6.41%,0.07%
其他,1213,838,375,30.9%,1.22%
药品研发服务,9268,2728,6540,70.57%,21.27%
医药流通,19455,17466,1989,10.22%,6.47%
医药制造,65072,43251,21821,33.53%,70.97%

太龙药业,600222,收入构成,报告日期,2016-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),27,31,-4,-13.59%,-0.03%
其他,424,214,210,49.46%,1.65%
药品研发服务,3586,815,2771,77.27%,21.8%
医药流通,6225,5281,945,15.18%,7.43%
医药制造,30552,21766,8787,28.76%,69.14%

太龙药业,600222,收入构成,报告日期,2015-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,246,216,31,12.4%,0.13%
其他,126,98,28,22.22%,0.11%
药品研发服务,7180,2259,4921,68.53%,20.27%
医药流通,34183,31442,2740,8.02%,11.29%
医药制造,60003,43443,16560,27.6%,68.21%

太龙药业,600222,收入构成,报告日期,2015-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,147,34,113,77.03%,1.06%
医药流通,17217,16027,1190,6.91%,11.12%
医药研发,2916,687,2229,76.44%,20.83%
医药制造,28713,21542,7171,24.98%,67%

太龙药业,600222,收入构成,报告日期,2014-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药制造,78066,56630,21436,27.46%,85.93%
医药商品流通,45980,43045,2935,6.38%,11.77%
其他（补充）,1377,802,575,41.73%,2.3%

太龙药业,600222,收入构成,报告日期,2014-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),1162,333,829,71.31%,7.69%
医药制造,38872,30084,8788,22.61%,81.53%
医药商品流通,22127,20965,1162,5.25%,10.78%

太龙药业,600222,收入构成,报告日期,2013-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),1307,501,806,61.68%,3.18%
医药制造,82200,59412,22787,27.72%,89.96%
医药商品流通,46961,45225,1737,3.7%,6.86%

太龙药业,600222,收入构成,报告日期,2013-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),482,-- ,482,--,4.97%
医药制造,31154,23134,8019,25.74%,82.71%
医药商品流通,28888,27694,1194,4.13%,12.32%

太龙药业,600222,收入构成,报告日期,2012-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),595,208,387,65.05%,2.11%
医药制造,33260,21951,11310,34%,61.8%
医药商品流通,75058,68453,6605,8.8%,36.09%

太龙药业,600222,收入构成,报告日期,2012-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药制造,13235,9115,4121,31.13%,60.74%
其他(补充),166,-- ,166,--,2.45%
医药商品流通,34164,31667,2497,7.31%,36.81%

太龙药业,600222,收入构成,报告日期,2011-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),3006,-- ,3006,--,22.88%
医药制造,23560,18314,5246,22.27%,39.92%
医药商品流通,71512,66625,4887,6.83%,37.2%

太龙药业,600222,收入构成,报告日期,2011-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),62,-- ,62,--,1.24%
医药制造,10115,6954,3161,31.25%,63.51%
医药商品流通,34774,33020,1754,5.04%,35.25%

太龙药业,600222,收入构成,报告日期,2010-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药制造,26294,18008,8287,31.51%,72.36%
医药商品流通,64856,61691,3165,4.88%,27.64%

太龙药业,600222,收入构成,报告日期,2010-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药制造,10828,6698,4130,38.14%,75.12%
医药商品流通,28110,26742,1368,4.87%,24.88%

太龙药业,600222,收入构成,报告日期,2009-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药制造,26549,17858,8691,32.73%,77.9%
医药商品流通,54653,52187,2466,4.51%,22.1%

太龙药业,600222,收入构成,报告日期,2009-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药制造,10444,6620,3824,36.61%,76.12%
医药商品流通,25465,24265,1200,4.71%,23.88%

太龙药业,600222,收入构成,报告日期,2008-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药制造,20101,12654,7447,37.05%,78.9%
医药商品流通,41034,39042,1992,4.85%,21.1%

太龙药业,600222,收入构成,报告日期,2008-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药行业,25161,20197,4964,19.73%,100%

太龙药业,600222,收入构成,报告日期,2007-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药制造,21202,14670,6532,30.81%,81.18%
医药商品流通,15893,14379,1514,9.53%,18.82%

太龙药业,600222,收入构成,报告日期,2007-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药行业,16814,12824,3990,23.73%,100%

太龙药业,600222,收入构成,报告日期,2006-12-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药行业,36454,28690,7764,21.3%,100%

太龙药业,600222,收入构成,报告日期,2006-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药行业,15793,12493,3300,20.89%,100%

太龙药业,600222,收入构成,报告日期,2006-03-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药商业,4480,4251,229,5.12%,16.3%
医药制造业,3589,2412,1177,32.81%,83.7%

太龙药业,600222,收入构成,报告日期,2005-06-30,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
商业,3923,3844,0,2%,0%
工业,6842,3788,0,44.64%,0%

太龙药业,600222,收入构成,报告日期,2005-03-31,
按行业,收入(万元),成本(万元),利润(万元),毛利率,利润占比
医药商业,2699,2641,0,2.16%,0%
医药制造,3382,1806,0,46.6%,0%


